SPCE Stock Jumps 22% on Virgin Galactic Flights, SpaceX IPO Buzz
SPCE stock surged more than 22% on May 29, 2026, reaching an all-time high near $5.58, as investors rotated into space stocks. The move was driven by three catalysts: (1) Virgin Galactic resumed VSS Unity glide flight testing after nearly two years, signaling operational readiness ahead of its Q3 2026 Delta-class timeline; (2) renewed SpaceX IPO excitement sparked broader “space sector” trading momentum, with SPCE viewed as a proxy for the IPO narrative; and (3) a preliminary court-approved settlement reduced legal uncertainty tied to 2022 shareholder derivative lawsuits. Investors are also tracking Virgin Galactic’s transition toward the next-generation Delta-class spacecraft and the reopening of ticket sales at $750,000 per seat.
Still, traders face a high-risk setup. SPCE stock remains minimally revenue-generating and deeply unprofitable, with negative free cash flow and ongoing operating losses. Near-term bullish continuation depends on hitting the Q3 2026 flight-testing milestones and maintaining funding through late-2026 commercial operations. Any delay or liquidity concern could quickly reverse sentiment in this volatile momentum trade.
Bullish
This is broadly bullish for the trading tape because SPCE stock is being lifted by multiple near-term, sentiment-friendly catalysts at once: a return to flight testing (operational de-risking), reduced legal overhang (lower perceived tail risk), and external IPO-driven sector momentum (flow/risk-on behavior). Similar multi-catalyst setups have historically produced sharp but sometimes fragile momentum in speculative equities—gains can extend quickly if guidance milestones are hit, but they can unwind just as fast on delays.
Short term: expect elevated volatility and momentum as traders front-run Q3 2026 glide/Delta-class progress and any incremental SpaceX IPO headlines. The legal settlement helps sustain bids by reducing “institutional avoidance” logic.
Long term: the market will likely keep reassessing SPCE on the gap between milestones and fundamentals (still minimal revenue and negative free cash flow). If commercial operations remain on schedule late-2026, the rally could mature; if not, the stock may revert to a funding/trajectory-risk discount, limiting follow-through beyond headline-driven spikes.